Oxygen Biotherapeutics’ (OXBT) Management Discusses Q4 2014 Results … – Seeking Alpha (registration)
Oxygen Biotherapeutics’ (OXBT) Management Discusses Q4 2014 Results …Seeking Alpha (registration)… the March 2014, $59 million public offering of common stock proceeds from the July 2013, $5.4 million public offering of Series C Preferred Stock and Warrants, and the exercise of certain outstanding warrants throughout the year for proceeds of $7 …Oxygen Biotherapeutics Announces Fiscal […]